Docetaxel: all 1,319 studies that test it

Page 3 of 14. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.

• Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck CarcinomaTerminatedNCT01794845Phase 2Results posted
• GTX-RT in Borderline Resectable Pancreatic CancerTerminatedNCT01754623Phase 2Results posted
• Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.CompletedNCT01750281Phase 2Results posted
• Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT01718353Phase 2Results posted
• Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.CompletedNCT01715233Phase 2Results posted
• Dose Dense TC + Pegfilgrastim Support for Breast CancerCompletedNCT01671319Phase 2Results posted
• CP-751,871 In Combination With Docetaxel In Advance Non-hematologic MalignanciesCompletedNCT01653158Phase 1Results posted
• Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.CompletedNCT01652469Phase 3Results posted
• Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)CompletedNCT01642004Phase 3Results posted
• Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal AdenocarcinomaTerminatedNCT01639131Phase 2Results posted
• External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate CancerTerminatedNCT01603420Phase 2/3Results posted
• A Study of Ramucirumab and Docetaxel in Participants With Solid TumorsCompletedNCT01567163Phase 2Results posted
• Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT01557959Phase 2Results posted
• Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by SurgeryTerminatedNCT01533207Phase 3Results posted
• Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast CancerCompletedNCT01527487Phase 2Results posted
• Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric CancerCompletedNCT01515748Phase 3Results posted
• S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CancerCompletedNCT01498289Phase 2Results posted
• Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01468532Phase 1/2Results posted
• Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic CancerCompletedNCT01459614Phase 2Results posted
• Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)CompletedNCT01446016Phase 2Results posted
• Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)CompletedNCT01443078Phase 2Results posted
• Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT01437449Phase 2Results posted
• Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in BladderTerminatedNCT01382706Phase 2Results posted
• GSK1120212 Rollover StudyTerminatedNCT01376310Phase 2Results posted
• Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung CancerCompletedNCT01350817Phase 2Results posted
• A Safety Study in Participants With Advanced Solid TumorsTerminatedNCT01284335Phase 1Results posted
• A Study of Ramucirumab (IMC-1121B) in Participants With Breast CancerCompletedNCT01256567Phase 1Results posted
• Docetaxel With or Without AZD6244 in MelanomaCompletedNCT01256359Phase 2Results posted
• Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With DocetaxelTerminatedNCT01253642Phase 2Results posted
• Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate CancerCompletedNCT01250717Phase 2Results posted
• BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLCCompletedNCT01243775Phase 2Results posted
• Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma StudyTerminatedNCT01221753Phase 2Results posted
• Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast CancerTerminatedNCT01220128Phase 2Results posted
• Trimodality Management of T1b Esophageal CancersCompletedNCT01217060Phase 1/2Results posted
• Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive StrategyCompletedNCT01209520Not applicableResults posted
• A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)CompletedNCT01204697Phase 2Results posted
• Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based TherapyCompletedNCT01129206Phase 2Results posted
• A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel RegimenCompletedNCT01094288Phase 1Results posted
• Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT01084655Phase 1/2Results posted
• Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate CancerCompletedNCT01076335Phase 2Results posted
• Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate CancerTerminatedNCT00996502Phase 1/2Results posted
• Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)CompletedNCT00996333Phase 2Results posted
• Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00970684Phase 2Results posted
• A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLCCompletedNCT00963807Phase 2Results posted
• A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate CancerCompletedNCT00942578Phase 2Results posted
• Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00938470Phase 2Results posted
• High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell TumorsCompletedNCT00936936Phase 2Results posted
• A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable CancerCompletedNCT00927589Phase 1Results posted
• Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT00896181Phase 2Results posted
• Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma SubtypesCompletedNCT00887809Phase 2Results posted
• The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00887315Phase 2Results posted
• A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic CancerCompletedNCT00882310Phase 2Results posted
• S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00872989Phase 2Results posted
• Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerTerminatedNCT00863512Phase 3Results posted
• Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate CancerTerminatedNCT00861471Phase 1/2Results posted
• Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence ScoresTerminatedNCT00832338Phase 2Results posted
• Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast CancerCompletedNCT00820872Phase 2Results posted
• LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung CancerCompletedNCT00805194Phase 3Results posted
• Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLCTerminatedNCT00801801Phase 2Results posted
• Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate CancerTerminatedNCT00786682Phase 2Results posted
• Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal JunctionCompletedNCT00757172Phase 2Results posted
• Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ AdenocarcinomaCompletedNCT00737438Phase 2Results posted
• Multimodality Phase II Study in Prostate CancerTerminatedNCT00734851Phase 2Results posted
• Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00721513Phase 2Results posted
• Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00720304Phase 2Results posted
• Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid TumorCompletedNCT00711243Phase 1/2Results posted
• Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus CancerTerminatedNCT00707473Phase 2Results posted
• Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00705874Phase 1Results posted
• Docetaxel in Node Positive Adjuvant Breast CancerCompletedNCT00688740Phase 3Results posted
• A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)CompletedNCT00687440Phase 2Results posted
• Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate CancerCompletedNCT00669162Phase 1/2Results posted
• Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryTerminatedNCT00665457Phase 2Results posted
• Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx CancerCompletedNCT00665392Phase 2Results posted
• Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00664105Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung CancerCompletedNCT00661778Phase 2Results posted
• A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary CancersCompletedNCT00660699Phase 2Results posted
• Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate CancerCompletedNCT00658697Phase 2Results posted
• Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLCCompletedNCT00647426Phase 2Results posted
• Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast CancerCompletedNCT00645333Phase 1/2Results posted
• Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLCCompletedNCT00621049Phase 2Results posted
• Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung CarcinomaTerminatedNCT00617656Phase 3Results posted
• Perioperative Therapy for Resectable Pancreatic CancerCompletedNCT00609336Phase 2Results posted
• Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)TerminatedNCT00599131Phase 2Results posted
• Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerTerminatedNCT00591149Phase 2Results posted
• Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone TherapyCompletedNCT00589420Phase 2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT00588770Phase 3Results posted
• Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate CancerCompletedNCT00587431Phase 2Results posted
• A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With CancerTerminatedNCT00584012Phase 1Results posted
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer PatientsTerminatedNCT00583622Phase 2Results posted
• Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate CancerTerminatedNCT00577356Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.TerminatedNCT00576901Phase 2Results posted
• Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube CancerCompletedNCT00569673Phase 2Results posted
• Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and AdolescentsCompletedNCT00565448Phase 2Results posted
• FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerCompletedNCT00564733Phase 2Results posted
• A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.CompletedNCT00559754Phase 2Results posted
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedNCT00551759Phase 2Results posted
• A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.CompletedNCT00545688Phase 2Results posted
• Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck CancerCompletedNCT00544414Phase 2Results posted
• Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)CompletedNCT00543387Phase 1Results posted
• Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00541099Phase 2Results posted

← Docetaxel overview